ReviewInnere Medizin (Heidelberg, Germany)2026
[Beta-blockers following myocardial infarction without heart failure: their role in the era of coronary reperfusion].
Review in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of a beta-blocker has been an integral part of treatment following myocardial infarction for decades. However, some of the studies on which this treatment recommendation is based were carried out half a century ago. In the meantime, the widespread establishment of coronary reperfusion in particular has fundamentally changed the treatment of acute myocardial infarction. For patients with preserved systolic left ventricular function, the benefit of beta-blocker therapy following myocardial infarction can currently no longer be clearly demonstrated. This review summarizes the evidence for beta-blocker therapy from the pre-coronary reperfusion era to the present era of coronary reperfusion.
Indexed as
Identifiers
41162673What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.